title: Treatment with valproic acid for myelofibrosis with myeloid metaplasia.
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Inoue
authors.forename: Takao
authors.initials: T
authors.lastname: Suzuki
authors.forename: Madoka
authors.initials: M
authors.lastname: Takimoto
authors.forename: Michiko
authors.initials: M
authors.lastname: Irei
authors.forename: Shinji
authors.initials: S
authors.lastname: Yoshioka
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Shibuya
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kato
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Koike
authors.forename: Masatomo
authors.initials: M
authors.lastname: Takahashi
mesh_terms: D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage*; D001772:Blood Cell Count; D004827:Epilepsy / Q000097:blood / Q000150:complications / Q000517:prevention & control; D005260:Female; D006470:Hemorrhage / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D055728:Primary Myelofibrosis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D014635:Valproic Acid / Q000008:administration & dosage* / Q000097:blood
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid